These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 27800591)

  • 21. Reporting of vertebral fragility fractures: can radiologists help reduce the number of hip fractures?
    Mitchell RM; Jewell P; Javaid MK; McKean D; Ostlere SJ
    Arch Osteoporos; 2017 Dec; 12(1):71. PubMed ID: 28785996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
    ; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Pignone M; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2018 Jun; 319(24):2521-2531. PubMed ID: 29946735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
    Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Nguyen ET; Posas-Mendoza T; Siu AM; Ahn HJ; Choi SY; Lim SY
    Osteoporos Int; 2018 Aug; 29(8):1827-1832. PubMed ID: 29744567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Osteoporosis liaison service].
    Suzuki A
    Nihon Rinsho; 2015 Oct; 73(10):1765-9. PubMed ID: 26529944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment of osteoporosis in the oldest old.
    Vandenbroucke A; Luyten FP; Flamaing J; Gielen E
    Clin Interv Aging; 2017; 12():1065-1077. PubMed ID: 28740372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
    Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
    Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of hip fractures: a nursing imperative.
    Lappe JM
    Orthop Nurs; 1998; 17(3):15-24; quiz 25-6. PubMed ID: 9847814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of senile osteoporosis and hip fractures.
    Duque G; Demontiero O; Troen BR
    Minerva Med; 2009 Feb; 100(1):79-94. PubMed ID: 19277006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
    Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.
    Lin X; Xiong D; Peng YQ; Sheng ZF; Wu XY; Wu XP; Wu F; Yuan LQ; Liao EY
    Clin Interv Aging; 2015; 10():1017-33. PubMed ID: 26150706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Goal-directed treatment of osteoporosis in Europe.
    Kanis JA; McCloskey E; Branco J; Brandi ML; Dennison E; Devogelaer JP; Ferrari S; Kaufman JM; Papapoulos S; Reginster JY; Rizzoli R
    Osteoporos Int; 2014 Nov; 25(11):2533-43. PubMed ID: 25199574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in treatment of glucocorticoid-induced osteoporosis.
    Hsu E; Nanes M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers to secondary fracture prevention in primary care.
    Mendis AS; Ganda K; Seibel MJ
    Osteoporos Int; 2017 Oct; 28(10):2913-2919. PubMed ID: 28664275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough?
    Kamel HK
    J Clin Rheumatol; 2005 Apr; 11(2):68-71. PubMed ID: 16357705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of previous fracture and anti-osteoporotic medication prescription in hip fracture patients.
    McCarthy CJ; Kelly MA; Kenny PJ
    Ir J Med Sci; 2022 Feb; 191(1):247-252. PubMed ID: 33687665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
    Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
    Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture.
    Cobden A; Cobden SB; Camurcu Y; Ucpunar H; Duman S; Sofu H
    Arch Osteoporos; 2019 Oct; 14(1):100. PubMed ID: 31628566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are we treating osteoporotic fractures of the hip adequately? A Middle Eastern cohort study.
    Venugopal Menon K; Al Harthy HHS; Al Habsi KSK; Al Ruzaiqi HAH
    Arch Osteoporos; 2018 Jan; 13(1):6. PubMed ID: 29368309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.